Hester Biosciences zooms 19% to hit 52-week high; Co in talks to produce Covaxin
Updated : May 17, 2021 10:18:04 IST
The company has tied up with the Gujarat government to explore the production of the COVID-19 vaccine through technology transfer from Bharat Biotech.
The stock rose as much as 19.1 percent to its 52-week high of Rs 2,944 per share on the BSE.
Published : May 17, 2021 10:18 AM IST